Walgreens Boots Alliance (NASDAQ:WBA) Sets New 52-Week Low at $17.49

Walgreens Boots Alliance, Inc. (NASDAQ:WBA)’s share price reached a new 52-week low during mid-day trading on Friday . The company traded as low as $17.49 and last traded at $17.91, with a volume of 1135772 shares trading hands. The stock had previously closed at $17.60.

Wall Street Analyst Weigh In

WBA has been the subject of several research reports. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. SVB Leerink decreased their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research report on Monday, March 18th. Truist Financial reiterated a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. UBS Group reduced their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 3rd. Finally, Barclays started coverage on Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price on the stock. Four analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $24.36.

Walgreens Boots Alliance Trading Up 1.3 %

The stock has a fifty day simple moving average of $20.09 and a 200 day simple moving average of $21.81. The firm has a market capitalization of $15.38 billion, a P/E ratio of -2.51, a PEG ratio of 1.10 and a beta of 0.73. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. During the same quarter last year, the company earned $1.16 EPS. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Insider Transactions at Walgreens Boots Alliance

In related news, Director Valerie B. Jarrett purchased 4,456 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were acquired at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the purchase, the director now directly owns 4,456 shares in the company, valued at $99,992.64. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CFO Manmohan Mahajan bought 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Valerie B. Jarrett purchased 4,456 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 29th. The stock was acquired at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the transaction, the director now directly owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 13,456 shares of company stock valued at $270,423. 17.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Walgreens Boots Alliance

A number of large investors have recently made changes to their positions in the business. Highlander Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Pineridge Advisors LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at $26,000. Venturi Wealth Management LLC raised its stake in shares of Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 981 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 308.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 845 shares during the last quarter. Finally, Rocky Mountain Advisers LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth about $30,000. 58.59% of the stock is currently owned by institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.